Trials / Completed
CompletedNCT01057238
Intensive Communication for Chronically Critically Ill
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 571 (actual)
- Sponsor
- Case Western Reserve University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was a trial of a formal system of family meetings to support family decision makers of chronically critically ill patients in the intensive care unit.
Detailed description
Formal family meetings have been recommended as a useful approach to assist in goal setting, facilitate decision making, and reduce use of ineffective resources in the ICU. We implemented an "intensive communication system" to test the effect of regular, structured formal family meetings on patient outcomes among long-stay ICU patients The design was a pre-post, tandem assignment of patients (n=217) receiving usual care and communication, followed by enrollment of intervention patients (n=354), from 5 ICUs. The "intensive communication system" included: (1) family meeting within 5 days of ICU admission and weekly thereafter; (2) each meeting addressed medical update, values and preferences, goals of care; treatment plan, and milestones for judging effectiveness of treatment. We measured differences between control and intervention patients in indicators of aggressiveness of care or timing of treatment limitation decisions (ICU mortality, LOS, duration of ventilation, treatment limitation orders, or use of tracheostomy or percutaneous gastrostomy). Difference in outcomes among patients who died or who had treatment limitation orders, comparing control and intervention groups, was also examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intensive Communication System | Regular family meetings once a week, using a standard protocol |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2008-04-01
- Completion
- 2008-05-01
- First posted
- 2010-01-27
- Last updated
- 2016-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01057238. Inclusion in this directory is not an endorsement.